Childrens Acetaminophen

Description

The product is identified by the SPL code 34089-3. No additional specific details regarding its chemical composition, dosage form, or physical characteristics are provided in the available information.

Uses and Indications

This drug is indicated for the reduction of fever and the relief of minor aches and pains associated with various conditions, including the common cold, influenza, headache, sore throat, immunizations, and toothache.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product should be administered with caution, as it does not contain directions or complete warnings for adult use. Prior to administration, the product must be shaken well.

Healthcare professionals are advised to determine the appropriate dose using the dosage chart provided below. When possible, dosing should be based on the patient's weight; if weight is not available, age may be used as a guide.

Dosing may be repeated every 4 hours as necessary, but it is imperative not to exceed 5 doses within a 24-hour period. Continuous use beyond 5 days should only occur under the guidance of a physician. The enclosed measuring cup must be utilized for accurate dosing.

Dosage Chart:

• For patients weighing under 24 lbs (under 2 years of age): Consult a doctor for appropriate dosing.

• For patients weighing 24-35 lbs (ages 2-3 years): Administer 1 teaspoon (5 mL).

• For patients weighing 36-47 lbs (ages 4-5 years): Administer 1½ teaspoons (7.5 mL).

• For patients weighing 48-59 lbs (ages 6-8 years): Administer 2 teaspoons (10 mL).

• For patients weighing 60-71 lbs (ages 9-10 years): Administer 2½ teaspoons (12.5 mL).

• For patients weighing 72-95 lbs (age 11 years): Administer 3 teaspoons (15 mL).

Contraindications

Use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or non-prescription, is prohibited due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

• This product should not be used in patients with a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation.

• Exceeding the recommended dosage while using this product is contraindicated, as it may lead to serious adverse effects.

Warnings and Precautions

Severe liver damage may occur in children taking this product, which contains acetaminophen, if they exceed the maximum daily amount of 5 doses within a 24-hour period or if they are concurrently using other medications that contain acetaminophen.

In cases of severe sore throat that persists for more than 2 days, or if it is accompanied or followed by fever, headache, rash, nausea, or vomiting, it is imperative to consult a healthcare professional promptly.

Healthcare providers should inquire about the presence of liver disease before recommending this product. Additionally, it is advisable to consult a doctor or pharmacist if the child is currently taking the anticoagulant warfarin, as interactions may occur.

When administering this product, it is crucial to adhere strictly to the recommended dosage to avoid the risk of overdose. In the event of an overdose, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended, as prompt medical attention is essential even in the absence of noticeable symptoms.

Patients should discontinue use and seek medical advice if new symptoms arise, if there is any redness or swelling, if pain worsens or persists beyond 5 days, or if fever intensifies or lasts more than 3 days. These symptoms may indicate a serious underlying condition that requires further evaluation.

Side Effects

Severe liver damage may occur in patients who exceed the maximum daily amount of five doses within a 24-hour period or who take this product in conjunction with other medications containing acetaminophen. Patients should be advised against using this product with any other drug that contains acetaminophen, whether prescription or non-prescription. If there is uncertainty regarding the presence of acetaminophen in another medication, consultation with a healthcare professional is recommended.

Patients experiencing a severe sore throat that persists for more than two days, or is accompanied by fever, headache, rash, nausea, or vomiting, should seek medical attention promptly. Additionally, it is crucial to consult a doctor before use if the patient has liver disease or is taking the blood-thinning medication warfarin.

During the use of this product, patients must adhere to the recommended dosage to avoid the risk of overdose. Signs that warrant discontinuation of use and consultation with a healthcare provider include the emergence of new symptoms, the presence of redness or swelling, worsening pain lasting more than five days, or a fever that worsens or persists beyond three days, as these may indicate a serious condition.

In the event of an overdose, which may lead to liver damage, immediate medical assistance should be sought, or contact with a Poison Control Center should be made. Quick medical attention is critical, even if no signs or symptoms are initially apparent.

Drug Interactions

Patients should consult a healthcare professional prior to using this medication if they are concurrently taking warfarin, a blood-thinning agent. The combination may increase the risk of bleeding due to potential pharmacodynamic interactions.

Additionally, this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or over-the-counter. The risk of acetaminophen overdose and associated hepatotoxicity may be heightened. If there is uncertainty regarding the presence of acetaminophen in other medications, it is advisable to seek guidance from a healthcare provider.

Packaging & NDC

Below are the non-prescription pack sizes of Childrens Acetaminophen (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 2 years of age should not be given this medication without consulting a doctor. For children aged 2 to 3 years weighing between 24-35 lbs, the recommended dose is 1 teaspoon (5 mL). For those aged 4 to 5 years and weighing 36-47 lbs, the dose increases to 1½ teaspoons (7.5 mL). Children aged 6 to 8 years, weighing 48-59 lbs, may receive 2 teaspoons (10 mL), while those aged 9 to 10 years and weighing 60-71 lbs can take 2½ teaspoons (12.5 mL). Finally, for children aged 11 years weighing 72-95 lbs, the dose is 3 teaspoons (15 mL).

It is important to note that this medication should not be used in conjunction with any other products containing acetaminophen, whether prescription or non-prescription. Caution is advised if the child has a known allergy to acetaminophen or any inactive ingredients in this product. Additionally, healthcare professionals should be consulted if the child has liver disease or is taking the anticoagulant warfarin. The medication should not be administered for more than 5 days unless directed by a physician. Parents and caregivers should ensure that the product is kept out of reach of children.

Geriatric Use

Elderly patients may not have specific information regarding the use of Children's Acetaminophen, as the drug insert does not provide data on geriatric use. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients.

It is advisable to consider the overall health status, potential for altered pharmacokinetics, and the presence of comorbidities in elderly patients. Monitoring for efficacy and safety is recommended, as age-related physiological changes may affect drug metabolism and response.

Due to the lack of specific data, healthcare providers should evaluate the necessity of dosage adjustments on a case-by-case basis, ensuring that the benefits of treatment outweigh any potential risks associated with its use in this population.

Pregnancy

The safety of acetaminophen during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider before use. Potential risks to the fetus are not clearly defined, and caution is advised when considering the use of acetaminophen during pregnancy. Dosage adjustments may be necessary, and it is important for healthcare professionals to provide guidance on appropriate dosing. Use of acetaminophen during pregnancy should be under the supervision of a healthcare professional to ensure the safety of both the mother and the developing fetus.

Lactation

Nursing mothers should consult a doctor before using this product. There is a potential for excretion in breast milk. The effects of this product on a nursing infant are not well studied; therefore, caution is advised.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment.

Hepatic Impairment

Patients with hepatic impairment should consult a healthcare professional prior to using this product, particularly if they have a history of liver disease. The product contains acetaminophen, which is known to pose a risk of severe liver damage, especially in patients with compromised liver function.

It is critical to adhere to the maximum daily dosage of acetaminophen, which is limited to 5 doses within a 24-hour period. Exceeding this limit may result in severe liver damage. Additionally, patients should be cautious about concomitant use of other medications containing acetaminophen, as this can further increase the risk of liver injury.

In the event of an overdose, which may occur if the recommended dosage is surpassed, immediate medical assistance should be sought. Contacting a Poison Control Center is advised, as prompt medical attention is essential, even if no signs or symptoms of overdose are apparent.

Overdosage

In the event of an overdose, the potential for liver damage increases significantly when the recommended dose is exceeded. It is imperative that healthcare professionals advise patients to seek immediate medical assistance or contact a Poison Control Center without delay.

Quick medical attention is crucial, even in the absence of noticeable signs or symptoms. Early intervention can be vital in mitigating the risks associated with overdose and preventing serious complications. Healthcare providers should ensure that patients are aware of the importance of prompt action in such situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question. Further studies may be necessary to elucidate these aspects of nonclinical toxicology.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications that contain acetaminophen, whether prescription or non-prescription. If patients are uncertain about the presence of acetaminophen in other medications, they should be encouraged to consult a doctor or pharmacist for clarification.

Patients should be cautioned against using this product if their child has a known allergy to acetaminophen or any of the inactive ingredients contained in the formulation. They should be instructed to stop use and seek medical advice if new symptoms arise, if there is any redness or swelling, or if pain worsens or persists beyond five days. Additionally, if a fever worsens or lasts more than three days, patients should be advised to discontinue use and consult a doctor, as these may indicate a serious underlying condition.

Healthcare providers should emphasize the importance of adhering to the recommended dosage and to be aware of the overdose warning associated with this product. It is also essential to recommend that patients consult a doctor before use if their child has liver disease. Furthermore, patients should be advised to speak with a doctor or pharmacist if their child is currently taking the blood-thinning medication warfarin, to ensure safe and effective use of this product.

Storage and Handling

The product is supplied in a configuration that includes specific NDC numbers, which are essential for identification and inventory management. It should be stored at room temperature, within the range of 15º to 30ºC (59º to 86ºF).

To ensure the integrity of the product, it must be protected from freezing and exposure to light. Additionally, it is crucial to observe tamper evidence; the product should not be used if the printed inner cap seal is broken or missing. Proper handling and storage conditions are vital to maintain the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally, with the option to repeat the dose every 4 hours as needed. Clinicians should advise patients not to exceed 5 doses within a 24-hour period and to limit use to a maximum of 5 days unless otherwise directed by a healthcare professional. There are no additional details available regarding laboratory tests, abuse information, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Childrens Acetaminophen, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)